Preventive lamivudine against reinfection by hepatitis B after liver transplantation
Niederau, C.
Zeitschrift für Gastroenterologie 35(5): 359-361
1997
ISSN/ISBN: 0044-2771 PMID: 9265396 Document Number: 476980
Document emailed within 1 workday
Related Documents
Jeng, L.B.; Ho, Y.C.; Lee, W.C.; Wang, C.C.; Wang, K.L.; Chen, S.C.; Chen, M.F.; Lin, D.Y.; Liaw, Y.F.; Tan, P.P. 1994: Clinical and pathologic features of hepatitis B virus reinfection after liver transplantation Transplantation Proceedings 26(4): 2263-2264Wu, L.-M.; Xu, X.; Zheng, S.-S. 2005: Hepatitis B virus reinfection after liver transplantation: related risk factors and perspective Hepatobiliary and Pancreatic Diseases International: Hbpd Int 4(4): 502-508
Karasu, Z.; Ozacar, T.; Akyildiz, M.; Demirbas, T.; Arikan, C.; Kobat, A.; Akarca, U.; Ersoz, G.; Gunsar, F.; Batur, Y.; Kilic, M.; Tokat, Y. 2004: Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation Antiviral Therapy 9(6): 921-927
Arnold, J.C.; O'Grady, J.G.; Otto, G.; Kommerell, B.; Alexander, G.J.; Williams, R. 1991: CMV reinfection/reactivation after liver transplantation Transplantation Proceedings 23(5): 2632-2633
Rambusch, E.G.; Nashan, B.; Tillmann, H.L.; Böker, K.H.; Schlitt, H.J.; Maschek, H.; Raab, R.; Manns, M.P. 1998: De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates Zeitschrift für Gastroenterologie 36(12): 1027-1035
Lu, Y.; Wang, B.; Yu, L.; Liu, C.; Wu, Z.; Pan, C-En. 2004: Lamivudine in prevention and treatment of recurrent HBV after liver transplantation Hepatobiliary and Pancreatic Diseases International: Hbpd Int 3(4): 504-507
Kitay-Cohen, Y.; Ben-Ari, Z.; Tur-Kaspa, R.; Fainguelernt, H.; Lishner, M. 2000: Extension of transplantation free time by lamivudine in patients with hepatitis B-induced decompensated cirrhosis Transplantation 69(11): 2382-2383
Van Thiel, D.H.; Friedlander, L.; Kania, R.J.; Molloy, P.J.; Hassanein, T.; Wahlstrom, E.; Faruki, H. 1997: Lamivudine treatment of advanced and decompensated liver disease due to hepatitis B Hepato-Gastroenterology 44(15): 808-812
Cavallari, A.; Vivarelli, M.; D'Errico, A.; Bellusci, R.; Scarani, P.; De Raffele, E.; Nardo, B.; Gozzetti, G. 1994: Acute necrotizing pancreatitis due to hepatitis B virus reinfection in a liver transplant recipient Transplantation Proceedings 26(6): 3649-3650
Papatheodoridis, G.V.; Davies, S.; Dhillon, A.P.; Teixeira, R.; Goulis, J.; Davidson, B.; Rolles, K.; Dusheiko, G.; Burroughs, A.K. 2001: The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis Transplantation 72(3): 412-418
Sharma, Y.R.; Miah, A.R.; Saha, S.K.; Mohammed, S.; Rahman, M.; Roy, P.K.; Hasan, M. 2004: A study on efficacy of lamivudine therapy in decompensated cirrhosis of liver due to chronic hepatitis B virus infection Nepal Medical College Journal: Nmcj 6(2): 106-111
Kao, J.H.; Lai, M.Y.; Chen, P.J.; Chen, D.S. 2001: Probable reinfection with hepatitis C virus in a chronic hepatitis C patient with a sustained response to combination therapy Journal of the Formosan Medical Association 100(12): 824-828
Gordon, F.D.; Poterucha, J.J.; Germer, J.; Zein, N.N.; Batts, K.P.; Gross, J.B.; Wiesner, R.; Persing, D. 1997: Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation Transplantation 63(10): 1419-1423
Kaneko, J.; Sugawara, Y.; Akamatsu, N.; Kokudo, N.; Makuuchi, M. 2004: Cholestatic hepatitis due to hepatitis C virus after a living donor liver transplantation Hepato-Gastroenterology 51(55): 243-244
Gane, E.J.; Maertens, G.; Ducatteeuw, A.; Qian, K.P.; Lau, J.Y.; Jones, H.; Davies, E.; Naoumov, N.V.; Williams, R. 1999: Antibodies to hepatitis C virus envelope proteins correlate with hepatitis C viraemia after liver transplantation Transplantation 67(1): 78-84
Marzano, A.; Marengo, A.; Andreone, P.; Volpes, R.; Canova, D.; Cursaro, C.; Riili, A.; Fiorentino, B.; Bacci, M.; Guazzini, S.; Burra, P. 2010: Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation Minerva Medica 101(6): 373-383
Maguire, D.; Heaton, N.D.; Smith, H.M. 2002: Failure of reactivation of hepatitis B after liver transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients Transplantation 73(3): 481-482
Krishnamoorthi, R.; Manickam, P.; Cappell, M.S. 2014: Liver transplantation of hepatitis B surface antigen positive donors to hepatitis B core antibody recipients: analysis of 27 patients Minerva Gastroenterologica E Dietologica 60(2): 113-118
Chen, J.-L.; Wang, L.; Yan, J.; Zhang, L.; Yu, H.; Fan, X.-L. 2007: Predictive factors of hepatitis B virus DNA negative conversion among patients with chronic hepatitis B during lamivudine therapy Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 21(3): 273-275
Xu, J.-h.; Yu, Y.-y.; Si, C.-w.; Chen, X.-y.; Han, Z.-h.; Chen, Y.; Li, X.-y. 2009: A clinical study of viral dynamic change in patients with hepatitis B e antigen positive chronic hepatitis B by lamivudine treatment Zhonghua Yi Xue Za Zhi 89(41): 2902-2905